Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.900
-0.040 (-2.06%)
At close: Dec 5, 2025, 4:00 PM EST
1.895
-0.005 (-0.29%)
After-hours: Dec 5, 2025, 7:36 PM EST

Caribou Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Cash & Equivalents
11.1416.2951.1658.34240.4215.95
Upgrade
Short-Term Investments
136.12193.24277.67189.33135.41-
Upgrade
Cash & Short-Term Investments
147.26209.54328.83247.66375.8315.95
Upgrade
Cash Growth
-35.46%-36.28%32.77%-34.10%2255.87%-67.75%
Upgrade
Accounts Receivable
1.11.421.572.452.641.48
Upgrade
Other Receivables
1.831.832.292.225.483.68
Upgrade
Receivables
2.933.253.864.668.125.16
Upgrade
Prepaid Expenses
1.934.814.946.373.851.82
Upgrade
Other Current Assets
3.391.781.221.553.391.38
Upgrade
Total Current Assets
155.51219.38338.84260.25391.1924.31
Upgrade
Property, Plant & Equipment
23.639.2940.4534.914.893.5
Upgrade
Long-Term Investments
12.149.1351.3377.0745.37.63
Upgrade
Other Long-Term Assets
3.785.521.591.540.980.61
Upgrade
Total Assets
194.98313.31432.21373.77442.3636.05
Upgrade
Accounts Payable
3.82.483.121.153.992.6
Upgrade
Accrued Expenses
17.4921.9419.6514.4112.098.15
Upgrade
Current Portion of Long-Term Debt
-----0.65
Upgrade
Current Portion of Leases
2.691.431.20.97--
Upgrade
Current Unearned Revenue
2.223.132.859.948.70.16
Upgrade
Other Current Liabilities
1.861.681.481.671.050.82
Upgrade
Total Current Liabilities
28.0630.6528.328.1325.8312.39
Upgrade
Long-Term Debt
-----0.92
Upgrade
Long-Term Leases
22.7825.0625.9126.78-0.1
Upgrade
Long-Term Unearned Revenue
1.763.326.115.9522.030.94
Upgrade
Long-Term Deferred Tax Liabilities
0.550.550.560.380.480.16
Upgrade
Other Long-Term Liabilities
-0.792.941.656.193.66
Upgrade
Total Liabilities
53.1460.3663.8172.8954.5318.16
Upgrade
Common Stock
0.010.010.010.010.010
Upgrade
Additional Paid-In Capital
711.77701.08667.65499.6485.757.43
Upgrade
Retained Earnings
-570.03-448.39-299.29-197.22-97.79-30.87
Upgrade
Comprehensive Income & Other
0.090.260.03-1.52-0.14-
Upgrade
Total Common Equity
141.85252.95368.4300.87387.83-23.44
Upgrade
Shareholders' Equity
141.85252.95368.4300.87387.8317.89
Upgrade
Total Liabilities & Equity
194.98313.31432.21373.77442.3636.05
Upgrade
Total Debt
25.4626.4927.1127.75-1.68
Upgrade
Net Cash (Debt)
133.75222.9345.3289.29413.5114.28
Upgrade
Net Cash Growth
-47.42%-35.45%19.36%-30.04%2796.73%-71.03%
Upgrade
Net Cash Per Share
1.452.474.684.7613.061.67
Upgrade
Filing Date Shares Outstanding
93.479390.3161.360.6610.39
Upgrade
Total Common Shares Outstanding
93.4792.3888.4561.0360.269.71
Upgrade
Working Capital
127.45188.73310.54232.12365.3611.92
Upgrade
Book Value Per Share
1.522.744.174.936.44-2.41
Upgrade
Tangible Book Value
141.85252.95368.4300.87387.83-23.44
Upgrade
Tangible Book Value Per Share
1.522.744.174.936.44-2.41
Upgrade
Machinery
17.4820.6516.9813.467.255.42
Upgrade
Construction In Progress
--8.20.990.01-
Upgrade
Leasehold Improvements
3.0211.522.241.881.71.18
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q